TAKING STOCK
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.o Hard pressed Enviromed, the health care group, has at last produced a modest pick-me-up. US litigation over whether it invented the technology for analysing lead in water has taken an encouraging turn with the burden of proof placed on Enviromed's opponent. With a company associated with a former director, Ron Zwanziger, continuing to build up its stake - it now has 16.1 per cent - the shares rose 4p to 25p. They were floated at 110p in the summer of 1993.
o Barcom, the plant hire group revamped by company doctor Doug Rogers, is bumping along at 35p. It returned to the black this year, making pounds 652,000, and should continue to make sharp progress as it reaps benefits from its takeover of Chepstow, a rival plant hire business.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments